These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 22392047

  • 1. Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease.
    Kuo HC, Yang YL, Chuang JH, Tiao MM, Yu HR, Huang LT, Yang KD, Chang WC, Lee CP, Huang YH.
    J Clin Immunol; 2012 Aug; 32(4):746-52. PubMed ID: 22392047
    [Abstract] [Full Text] [Related]

  • 2. Hepcidin-Induced Iron Deficiency Is Related to Transient Anemia and Hypoferremia in Kawasaki Disease Patients.
    Huang YH, Kuo HC, Huang FC, Yu HR, Hsieh KS, Yang YL, Sheen JM, Li SC, Kuo HC.
    Int J Mol Sci; 2016 May 12; 17(5):. PubMed ID: 27187366
    [Abstract] [Full Text] [Related]

  • 3. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
    PLoS One; 2015 May 12; 10(12):e0144603. PubMed ID: 26658843
    [Abstract] [Full Text] [Related]

  • 4. Hepcidin in Kawasaki disease: upregulation by acute inflammation in patients having resistance to intravenous immunoglobulin therapy.
    Ishikawa T, Wada Y, Namba H, Kawai T.
    Clin Rheumatol; 2021 Dec 12; 40(12):5019-5024. PubMed ID: 34148165
    [Abstract] [Full Text] [Related]

  • 5. Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease.
    Kuo HC, Wang CL, Liang CD, Yu HR, Huang CF, Wang L, Hwang KP, Yang KD.
    Pediatr Allergy Immunol; 2009 May 12; 20(3):266-72. PubMed ID: 19438983
    [Abstract] [Full Text] [Related]

  • 6. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y, Wu J, Fang XY, Lin Z, Wu BY, Cai RY, Xu XY, Zheng H.
    Zhonghua Er Ke Za Zhi; 2004 Sep 12; 42(9):688-92. PubMed ID: 15482673
    [Abstract] [Full Text] [Related]

  • 7. IL-31 associated with coronary artery lesion formation in Kawasaki disease.
    Tseng WN, Lo MH, Guo MM, Hsieh KS, Chang WC, Kuo HC.
    PLoS One; 2014 Sep 12; 9(8):e105195. PubMed ID: 25122210
    [Abstract] [Full Text] [Related]

  • 8. Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker.
    Huang YH, Kuo HC.
    Int J Mol Sci; 2017 Apr 12; 18(4):. PubMed ID: 28417923
    [Abstract] [Full Text] [Related]

  • 9. Inflammation-induced hepcidin-25 is associated with the development of anemia in septic patients: an observational study.
    van Eijk LT, Kroot JJ, Tromp M, van der Hoeven JG, Swinkels DW, Pickkers P.
    Crit Care; 2011 Apr 12; 15(1):R9. PubMed ID: 21219610
    [Abstract] [Full Text] [Related]

  • 10. Tight junction protein ZO-1 in Kawasaki disease.
    Lai WT, Lee HC, Huang YH, Lo MH, Kuo HC.
    BMC Pediatr; 2021 Mar 31; 21(1):157. PubMed ID: 33789621
    [Abstract] [Full Text] [Related]

  • 11. Expression of Fc<gamma>Rs on monocytes among Kawasaki disease patients with coronary artery lesions.
    Xia Y, Tian X, Li Q, Wang G, Li C, Yang J.
    Int Immunopharmacol; 2017 Apr 31; 45():1-5. PubMed ID: 28147297
    [Abstract] [Full Text] [Related]

  • 12. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T, Ohara T, Muto T, Okumura A, Baba R, Koizumi Y, Yamagishi Y, Mikamo H, Daigo K, Hamakubo T.
    Front Immunol; 2021 Apr 31; 12():624802. PubMed ID: 33912155
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
    Wu Y, Liu FF, Xu Y, Wang JJ, Samadli S, Wu YF, Liu HH, Chen WX, Luo HH, Zhang DD, Wei W, Hu P.
    Clin Exp Med; 2019 May 31; 19(2):173-181. PubMed ID: 30617865
    [Abstract] [Full Text] [Related]

  • 14. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
    Nandi A, Pal P, Basu S.
    Rheumatol Int; 2019 Oct 31; 39(10):1797-1801. PubMed ID: 31302740
    [Abstract] [Full Text] [Related]

  • 15. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
    Chang LS, Lo MH, Li SC, Yang MY, Hsieh KS, Kuo HC.
    Oncotarget; 2017 Jan 10; 8(2):2044-2052. PubMed ID: 27893416
    [Abstract] [Full Text] [Related]

  • 16. Serum Lp-PLA2 Level Predicting Coronary Artery Lesions in Children with Kawasaki Disease.
    Zhang X, Ya-Wang Shao, Ya-Lan Zhang, Yi Liu.
    Heart Surg Forum; 2021 Jul 26; 24(4):E611-E618. PubMed ID: 34473042
    [Abstract] [Full Text] [Related]

  • 17. Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease.
    Wang CL, Wu YT, Liu CA, Lin MW, Lee CJ, Huang LT, Yang KD.
    Pediatrics; 2003 Feb 26; 111(2):E140-7. PubMed ID: 12563087
    [Abstract] [Full Text] [Related]

  • 18. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
    Bal AK, Prasad D, Umali Pamintuan MA, Mammen-Prasad E, Petrova A.
    Pediatr Neonatol; 2014 Oct 26; 55(5):387-92. PubMed ID: 24636168
    [Abstract] [Full Text] [Related]

  • 19. Association between adipokines and coronary artery lesions in children with Kawasaki Disease.
    Kim HJ, Choi EH, Kil HR.
    J Korean Med Sci; 2014 Oct 26; 29(10):1385-90. PubMed ID: 25368492
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
    Arthritis Rheum; 2013 Mar 26; 65(3):805-14. PubMed ID: 23440694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.